News from the world
16
Jul
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry of Health (incorporating the New Zealand Medicines and Medical Devices Safety Authority - Medsafe) this week, to strengthen collaboration and exchange of information on medicinal products. The agreement was signed by DG SANTE Director-General Sandra Gallina and EMA Executive Director Emer Cooke. Director-General Audrey Sonerson signed for the New Zealand Ministry of Health. The purpose of this Working Arrangement is to strengthen cooperation between signatories across a range of areas in public health, while promoting the timely, secure exchange of information. Deliverables from the Arrangement will include: The Arrangement will run from 6 July 2026 [European Commission]
17
Jul
Inside Pharma’s Push for More Resilient Supply Chains
Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...
17
Jul
US FDA CDER plans new guidance on AI, electronic safety report submissions, and more
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has...
15
Jul
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...
14
Jul
China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance
The National Medical Products Administration (NMPA) conducted its 2025 annual management review of the...
latest news
13 Jul
Stupefacenti, nuova circolare del Ministero: regole su custodia, giacenze, responsabilità e registri
26 Jun
FIS di Montecchio Maggiore accelera il percorso di decarbonizzazione industriale
26 Jun
FIS accelera sulla sostenibilità: biometano e taglio del 63% delle emissioni entro il 2035
26 Jun
US FDA investigator, experts seek to dispel misperceptions around 483s
26 Jun
AIFA - Aggiornate le Q&A sui processi autorizzativi AIC
26 Jun
US FDA Issues FY2025 Report on the State of Pharmaceutical Quality
19 Jun
Acque reflue. Il Parlamento UE chiede la sospensione e la revisione della direttiva
19 Jun
Australian Regulator Floats Plan To Make GMP Inspection Results Public